ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

4.7 (97) · $ 26.50 · In stock

Stock Market News 2022-04-28

FDA grants clearance to ClearPoint Neuro's SmartFrame Array

Katelyn McCray on LinkedIn: ClearPoint Neuro, Inc. strides to

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases

Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain

Stephanie Newton Korszen on LinkedIn: ClearPoint Neuro Announces

Neuspera Medical® Announces FDA Clearance of its System for

NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG

face recognition,facial recognition software,facial recognition

You may also like